This inventor holds 3 USPTO granted patents. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Bio Co., Ltd.. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2011
Title: Hirofumi Endo: Innovator in Biochemical Research
Introduction
Hirofumi Endo is a notable inventor based in Machida, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of HMG-CoA reductase inhibitors. With a total of 3 patents to his name, Endo's work has had a lasting impact on pharmaceutical research.
Latest Patents
Endo's latest patents include a process for producing HMG-CoA reductase inhibitors. This invention relates to a protein derived from a microorganism belonging to a specific genus, which has the activity of hydroxylating a compound represented by a particular formula. Additionally, he has developed DNA encoding hydroxylase, which also pertains to the same microorganism and its hydroxylating capabilities.
Career Highlights
Throughout his career, Hirofumi Endo has worked with prominent companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Bio Co., Ltd. His expertise in biochemistry has allowed him to contribute to various innovative projects within these organizations.
Collaborations
Endo has collaborated with esteemed colleagues in his field, including Yoshiyuki Yonetani and Hiroshi Mizoguchi. These partnerships have further enhanced his research and development efforts.
Conclusion
Hirofumi Endo's contributions to biochemistry and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence the development of important medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile